DK3797155T3 - Optimering af nk-92-cellevækst ved hjælp af poloxamer - Google Patents
Optimering af nk-92-cellevækst ved hjælp af poloxamer Download PDFInfo
- Publication number
- DK3797155T3 DK3797155T3 DK19730234.2T DK19730234T DK3797155T3 DK 3797155 T3 DK3797155 T3 DK 3797155T3 DK 19730234 T DK19730234 T DK 19730234T DK 3797155 T3 DK3797155 T3 DK 3797155T3
- Authority
- DK
- Denmark
- Prior art keywords
- poloxamer
- optimization
- cell growth
- growth
- cell
- Prior art date
Links
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 title 1
- 230000010261 cell growth Effects 0.000 title 1
- 238000005457 optimization Methods 0.000 title 1
- 229960000502 poloxamer Drugs 0.000 title 1
- 229920001983 poloxamer Polymers 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862674723P | 2018-05-22 | 2018-05-22 | |
| PCT/US2019/033312 WO2019226649A1 (en) | 2018-05-22 | 2019-05-21 | Optimization of nk-92 cell growth using poloxamer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3797155T3 true DK3797155T3 (da) | 2022-08-29 |
Family
ID=66827004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19730234.2T DK3797155T3 (da) | 2018-05-22 | 2019-05-21 | Optimering af nk-92-cellevækst ved hjælp af poloxamer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210363484A1 (da) |
| EP (1) | EP3797155B1 (da) |
| JP (1) | JP7208262B2 (da) |
| KR (2) | KR102587512B1 (da) |
| CN (1) | CN112166184A (da) |
| AU (1) | AU2019272583B2 (da) |
| CA (1) | CA3098471C (da) |
| DK (1) | DK3797155T3 (da) |
| ES (1) | ES2925553T3 (da) |
| IL (1) | IL278384B2 (da) |
| WO (1) | WO2019226649A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115521915B (zh) * | 2022-11-30 | 2023-03-21 | 江苏谱新生物医药有限公司 | 一种car-nk细胞及其制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08500242A (ja) * | 1992-06-24 | 1996-01-16 | メルク エンド カンパニー インコーポレーテッド | インターロイキン１β前駆体の転換酵素をコードするＤＮＡ |
| EP2243827B2 (en) * | 1996-08-30 | 2017-11-22 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| US8034332B2 (en) | 1997-04-30 | 2011-10-11 | Conkwest, Inc. | Interleukin-secreting natural killer cell lines and methods of use |
| DE69834257T2 (de) | 1997-04-30 | 2007-01-04 | Klingemann, Hans | Natürliche killerzelllinien und verfahren zu ihrer verwendung |
| WO1999024566A1 (en) | 1997-11-06 | 1999-05-20 | Roche Diagnostics Gmbh | Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| EP1117691A1 (en) | 1998-10-05 | 2001-07-25 | Ludwig Institute For Cancer Research | Methods for producing human tumor antigen specific antibodies |
| US7098008B2 (en) | 2000-04-25 | 2006-08-29 | Ic&G Do. Ltd. | Selected primers for detection of MAGE or GAGE genes for diagnosis of cancer and methods of use |
| US20050153419A1 (en) * | 2003-12-23 | 2005-07-14 | Schering Corporation | Methods for producing cell lines stable in serum-free medium suspension culture |
| CA3052445C (en) | 2004-07-10 | 2023-08-22 | Kerry S. Campbell | Genetically modified human natural killer cell lines |
| CA2803391C (en) | 2010-06-22 | 2021-11-09 | Neogenix Oncology, Inc. | Npc1 antibodies that bind a muc5ac epitope |
| PT3012268T (pt) | 2010-09-08 | 2018-01-31 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Recetores de antigénio quimérico com uma região de charneira otimizada |
| CN104126009B (zh) | 2011-10-07 | 2019-05-10 | 国立大学法人三重大学 | 嵌合抗原受体 |
| AU2012325915A1 (en) | 2011-10-20 | 2014-04-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-CD22 chimeric antigen receptors |
| AU2013312838B2 (en) | 2012-09-04 | 2018-11-29 | Cellectis | Multi-chain chimeric antigen receptor and uses thereof |
| US20150329640A1 (en) | 2012-12-20 | 2015-11-19 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
| AU2017340633B2 (en) | 2016-10-05 | 2024-01-11 | University Of Central Florida Research Foundation, Inc. | Methods and compositions related to NK cell and anti-PDL1 cancer therapies |
| AU2017356942A1 (en) | 2016-11-08 | 2019-05-23 | Calithera Biosciences, Inc. | Arginase inhibitor combination therapies |
| CN107674860A (zh) * | 2017-07-14 | 2018-02-09 | 上海源培生物科技股份有限公司 | Nk92细胞无血清培养基 |
-
2019
- 2019-05-21 DK DK19730234.2T patent/DK3797155T3/da active
- 2019-05-21 JP JP2020564837A patent/JP7208262B2/ja active Active
- 2019-05-21 KR KR1020207036562A patent/KR102587512B1/ko active IP Right Grant
- 2019-05-21 KR KR1020237034001A patent/KR20230146128A/ko active IP Right Grant
- 2019-05-21 CA CA3098471A patent/CA3098471C/en active Active
- 2019-05-21 EP EP19730234.2A patent/EP3797155B1/en active Active
- 2019-05-21 IL IL278384A patent/IL278384B2/en unknown
- 2019-05-21 AU AU2019272583A patent/AU2019272583B2/en active Active
- 2019-05-21 US US17/057,494 patent/US20210363484A1/en active Pending
- 2019-05-21 ES ES19730234T patent/ES2925553T3/es active Active
- 2019-05-21 CN CN201980033586.2A patent/CN112166184A/zh active Pending
- 2019-05-21 WO PCT/US2019/033312 patent/WO2019226649A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| CA3098471C (en) | 2023-04-18 |
| KR20230146128A (ko) | 2023-10-18 |
| CA3098471A1 (en) | 2019-11-28 |
| IL278384A (da) | 2020-12-31 |
| JP2021524743A (ja) | 2021-09-16 |
| EP3797155B1 (en) | 2022-06-15 |
| AU2019272583B2 (en) | 2022-01-06 |
| AU2019272583A1 (en) | 2020-11-05 |
| IL278384B2 (en) | 2024-02-01 |
| KR102587512B1 (ko) | 2023-10-11 |
| EP3797155A1 (en) | 2021-03-31 |
| CN112166184A (zh) | 2021-01-01 |
| KR20210011978A (ko) | 2021-02-02 |
| IL278384B1 (en) | 2023-10-01 |
| US20210363484A1 (en) | 2021-11-25 |
| ES2925553T3 (es) | 2022-10-18 |
| WO2019226649A1 (en) | 2019-11-28 |
| JP7208262B2 (ja) | 2023-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3504229T3 (da) | Regulering af genekspression ved anvendelse af manipulerede nukleaser | |
| DK3515296T3 (da) | Måling af vævslevedygtighed | |
| DK3536025T3 (da) | Identificering af en stråle til adgang til en målcelle af en trådløs handover | |
| DK3943070T3 (da) | Langtidsvirkende formuleringer af bedaquilin | |
| DK3927899T3 (da) | Nedvibrering af funderinger | |
| DK3811927T3 (da) | Stabil, parenteral doseringsform af cetrorelixacetat | |
| JP1730980S (ja) | パラソル | |
| JP1730979S (ja) | パラソル | |
| DK3567245T3 (da) | Drift af vindmølle | |
| DK3724319T3 (da) | Fremgangsmåder til opnåelse af muskelafledte celler | |
| DK3678644T3 (da) | Formuleringer af copanlisib | |
| ES2975982T3 (es) | Microscopía óptica | |
| DK3626814T3 (da) | Fremstilling af cellesfæroider | |
| JP1648879S (ja) | 双眼鏡 | |
| DK3797155T3 (da) | Optimering af nk-92-cellevækst ved hjælp af poloxamer | |
| DK3880802T3 (da) | Forbedret fremgangsmåde til fremstilling af t-celler | |
| DK3942020T3 (da) | Metoder til opnåelse af inducerede gladte muskelceller | |
| JP1648880S (ja) | 双眼鏡 | |
| TWI799569B (zh) | 固體電解質接合體 | |
| DK3402775T5 (da) | Fremgangsmåde til fremstilling af 2-(4-chlor-2,6-dimethylphenyl)ethanol | |
| DK3662761T3 (da) | Opbevaringsstabile adsorbater af nitrooxyforbindelser | |
| ES1225564Y (es) | Parasol | |
| ES1206711Y (es) | Apilamiento de maletas | |
| DE112021007801A5 (de) | Mehrfachteleskop | |
| ES1306463Y (es) | Paraguas |